TARA
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. (TARA) has 4 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 1, 2026.
Insiders have net sold $1.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jesse Shefferman
- Employees:28
- HQ:New York City, NY, US
- IPO:2014-10-22
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$230.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Shefferman JesseFirst filing | CEO and President | Sale | 215,687 | $882K | Jul 1 | SEC ↗ |
| Chief R&D Officer | Sale | 1,134 | $6K | Apr 9 | SEC ↗ | |
Zummo JacquelineFirst filing | Chief R&D Officer | Sale | 22,598 | $119K | Apr 2 | SEC ↗ |
Related companies
Protara Therapeutics, Inc. is in the Healthcare sector.